We are live on ! Find out more
LUCD icon

Lucid Diagnostics

33 hedge funds and large institutions have $2.8M invested in Lucid Diagnostics in 2024 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 8 increasing their positions, 8 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

83% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 6

40% more capital invested

Capital invested by funds: $2M → $2.8M (+$805K)

14% more funds holding

Funds holding: 2933 (+4)

1.04% more ownership

Funds ownership: 4.54%5.58% (+1%)

0% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 8

Holders
33
Holders Change
+4
Holders Change %
+13.79%
% of All Funds
0.43%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.01%
New
11
Increased
8
Reduced
8
Closed
6
Calls
Puts
Net Calls
Net Calls Change

LUCD Hedge Fund Activity: Q4 2024 in Review

33 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Lucid Diagnostics (LUCD) for Q4 2024, worth a combined $2.8M — up 40% from $2M a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new LUCD positions and 6 closed out — a net gain of 5 holders — while 8 added to existing stakes and 8 trimmed.

The largest buyer was Sargent Investment Group, opening a new position worth an estimated $478K. The largest seller was Luminus Management, cutting an estimated $120K.

  • 33 institutional investors held Lucid Diagnostics (LUCD) as of Q4 2024, up from 29 in Q3 2024.
  • Funds reported $2.8M of Lucid Diagnostics stock for Q4 2024, up 40% quarter-over-quarter.
  • 11 funds opened new Lucid Diagnostics positions in Q4 2024 and 6 closed out, a net change of +5 holders.
  • The largest Lucid Diagnostics buyer in Q4 2024 was Sargent Investment Group, an estimated $478K added.
  • The largest Lucid Diagnostics seller in Q4 2024 was Luminus Management, an estimated $120K sold.

Based on aggregated 13F filings for Q4 2024.